Allergy

Dual-purpose therapeutics help patients with both conditions.

Bruder Healthcare expands their dry eye portfolio by entering a distribution agreement with AllerFocus for its Percutaneous Allergy Test.

A look back on what's happened in optometry during the week of March 3-March 9.

Treatment should be adjusted based on disease severity.

FDA-approved steroid offers short-term relief for ocular surface inflammation.

Ensure successful symptoms management with your patients.

Consider topical therapies as second-line treatments for this patient base.

Canine patient case study reveals a surprising diagnosis

Check out our latest poll!

Check out our latest poll!

Researchers report a recombinant biologic derived from blood-feeding ticks may be a potential treatment for allergic eye disease

Address key factors and causes to ensure a proper diagnosis and treatment plan

Clinicians can offer patients both prescription and OTC options

Reducing inflammation and managing corneal microtrauma are new strategies

How Jimmie Johnson relieves his ocular allergies

Understand dry eye’s various factors and causes to get ahead of the treatment curve

Flip the eyelids to uncover the clinical features of allergic conjunctivitis

New drug from Gensight Biologics hits pipeline

Pollen, ragweed, grass, animal hair, and dander allergies targeted by new eyedrops

New devices will monitor health, enhance vision, and treat the eye

Allergy sufferers are more likely to develop ocular symptoms with scleral lens wear.

OSD treatments are rarely straightforward because of its complex, multifactorial nature.

A new age of highly customized therapeutic care is coming to the allergy treatment market.

Early and correct diagnosis of this congenital retinal vasculopathy vital to improve visual outcomes.